220 related articles for article (PubMed ID: 16710846)
1. Nitric oxide donor molsidomine attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801.
Pitsikas N; Zisopoulou S; Sakellaridis N
J Neurosci Res; 2006 Aug; 84(2):299-305. PubMed ID: 16710846
[TBL] [Abstract][Full Text] [Related]
2. The selective 5-HT(6) receptor antagonist Ro 04-6790 attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801.
Pitsikas N; Zisopoulou S; Pappas I; Sakellaridis N
Behav Brain Res; 2008 Apr; 188(2):304-9. PubMed ID: 18164078
[TBL] [Abstract][Full Text] [Related]
3. Memantine and recognition memory: possible facilitation of its behavioral effects by the nitric oxide (NO) donor molsidomine.
Pitsikas N; Sakellaridis N
Eur J Pharmacol; 2007 Oct; 571(2-3):174-9. PubMed ID: 17628527
[TBL] [Abstract][Full Text] [Related]
4. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
Zajaczkowski W; Czyrak A; Wedzony K
Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
[TBL] [Abstract][Full Text] [Related]
5. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
Klamer D; Zhang J; Engel JA; Svensson L
Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002
[TBL] [Abstract][Full Text] [Related]
6. A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities.
Rujescu D; Bender A; Keck M; Hartmann AM; Ohl F; Raeder H; Giegling I; Genius J; McCarley RW; Möller HJ; Grunze H
Biol Psychiatry; 2006 Apr; 59(8):721-9. PubMed ID: 16427029
[TBL] [Abstract][Full Text] [Related]
7. MK-801 can exacerbate or attenuate behavioral alterations associated with neonatal alcohol exposure in the rat, depending on the timing of administration.
Thomas JD; Fleming And SL; Riley EP
Alcohol Clin Exp Res; 2001 May; 25(5):764-73. PubMed ID: 11371726
[TBL] [Abstract][Full Text] [Related]
8. Role of NMDA receptor in the effects of arginine-vasopressin on memory processes.
Artemowicz B; Wiśniewski K
Pol J Pharmacol; 1998; 50(1):5-14. PubMed ID: 9662733
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio).
Seibt KJ; Oliveira Rda L; Zimmermann FF; Capiotti KM; Bogo MR; Ghisleni G; Bonan CD
Behav Brain Res; 2010 Dec; 214(2):417-22. PubMed ID: 20600350
[TBL] [Abstract][Full Text] [Related]
10. Early postnatal depletion of NMDA receptor development affects behaviour and NMDA receptor expression until later adulthood in rats--a possible model for schizophrenia.
Baier PC; Blume A; Koch J; Marx A; Fritzer G; Aldenhoff JB; Schiffelholz T
Behav Brain Res; 2009 Dec; 205(1):96-101. PubMed ID: 19539658
[TBL] [Abstract][Full Text] [Related]
11. Brain serotonin depletion by lesions of the median raphe nucleus enhances the psychotomimetic action of phencyclidine, but not dizocilpine (MK-801), in rats.
Kusljic S; Brosda J; Norman TR; van den Buuse M
Brain Res; 2005 Jul; 1049(2):217-26. PubMed ID: 15953591
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of the N-methyl-d-aspartate receptor antagonist MK-801 on different stages of object recognition memory in mice.
Nilsson M; Hansson S; Carlsson A; Carlsson ML
Neuroscience; 2007 Oct; 149(1):123-30. PubMed ID: 17826918
[TBL] [Abstract][Full Text] [Related]
13. The 5-HT1A receptor and recognition memory. Possible modulation of its behavioral effects by the nitrergic system.
Pitsikas N; Tsitsirigou S; Zisopoulou S; Sakellaridis N
Behav Brain Res; 2005 Apr; 159(2):287-93. PubMed ID: 15817191
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801.
Seillier A; Giuffrida A
Behav Brain Res; 2009 Dec; 204(2):410-5. PubMed ID: 19716985
[TBL] [Abstract][Full Text] [Related]
15. MK-801 administration during ethanol withdrawal in neonatal rat pups attenuates ethanol-induced behavioral deficits.
Thomas JD; Weinert SP; Sharif S; Riley EP
Alcohol Clin Exp Res; 1997 Oct; 21(7):1218-25. PubMed ID: 9347082
[TBL] [Abstract][Full Text] [Related]
16. Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801 Clz and MK-801 in KO1A mice.
Scorza MC; Castañé A; Bortolozzi A; Artigas F
Neuropharmacology; 2010; 59(1-2):112-20. PubMed ID: 20412811
[TBL] [Abstract][Full Text] [Related]
17. Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist.
Perera PY; Lichy JH; Mastropaolo J; Rosse RB; Deutsch SI
Eur Neuropsychopharmacol; 2008 Nov; 18(11):814-9. PubMed ID: 18674888
[TBL] [Abstract][Full Text] [Related]
18. Developmental lead (Pb) exposure reduces the ability of the NMDA antagonist MK-801 to suppress long-term potentiation (LTP) in the rat dentate gyrus, in vivo.
Gilbert ME; Lasley SM
Neurotoxicol Teratol; 2007; 29(3):385-93. PubMed ID: 17350801
[TBL] [Abstract][Full Text] [Related]
19. Involvement of N-methyl-d-aspartate (NMDA) receptors in a rat model of visceral hypersensitivity.
Gaudreau GA; Plourde V
Behav Brain Res; 2004 Apr; 150(1-2):185-9. PubMed ID: 15033291
[TBL] [Abstract][Full Text] [Related]
20. Effects of sub-anesthetic doses of ketamine on rats' spatial and non-spatial recognition memory.
Pitsikas N; Boultadakis A; Sakellaridis N
Neuroscience; 2008 Jun; 154(2):454-60. PubMed ID: 18472348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
